뉴스
- Samsung Bio·VUNO Fall on Rights Offerings…SHINPOONG·CHO-A↑[K-Bio Pulse] On Aug. 28, major pharmaceutical and biotech companies saw mixed stock performances as investors responded to various corporate events.Samsung Biologics shares plunged 6.78% following the company&rsq...
- DRTech·TissueGene·Finemedix, All Rally [K-bio Pulse] On the 13th, three names in Korea's pharmaceutical, biotech and healthcare sector — DRTech, KolonTissueGene DR Tech and FinemediX rose on the back of imp...
- Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse] , with bargain hunting returning to beaten-down growth and biotech names. While many of the d...
- Market Fluctuates, Daehwa Pharm, LabGenomics, and NeoImmuneTech Rise[K-Bio Pulse] On the 7th, amid mixed trading in the South Korean stock market, pharmaceutical and biotech companies
- FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls... On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock split...
- [K-Bio Pulse]Biotech Stocks Defy 'Black Tuesday' as MedPacto Soars, Bioinfra Faces Dead... Despite the "Black Tuesday" selloff on July 28, several biotech stocks bucked the broader market. As the Kosdaq tumbled, Cellid, Bioinfra, and MedPacto all hit the daily upper limit.
- Rokit, AprilBio Hit Limit-Up...HanAll Jumps on Own Catalyst[K-Bio Pulse] The biotech and healthcare sector saw a rare wave of positive momentum on June 24, helped by sentiment surrounding the 2026 BIO International Convention, or BIO USA, the world’s largest biotech...
- Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended its selloff following another U.S.
- Lemon Healthcare Rebounds to Limit-Up on Second Trading Day; D&D Pharmatech, PharmaResearch Also ... South Korea's pharmaceutical and biotech sector posted broad gains on Tuesday despite heightened market volatility that triggered a sell-side sidecar on the benchmark stock market early in the sessio...
- Peptron Sinks on Fading Lilly Hopes; Nature Cell, BL Pharmtech Hit Limit-Up [K-Bio Pulse] On July 9, South Korean pharmaceutical and biotech stocks saw sharply divergent moves, with Nature Cell and BL Pharmtech both hitting the daily upper limit, while Peptron tumbled to the lower limit i...
1 페이지
다음 →